BNY Mellon Innovators ETF
BKIV
NASDAQ Global Market- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- BNY Mellon Innovators ETF (BKIV) is an actively managed exchange-traded fund that seeks long-term capital growth by investing principally in equity securities of U.S. innovation-driven companies across the market capitalization spectrum; these companies, through their intellectual property, provide leading-edge products or services that are transformative or disruptive to existing business practices, such as new medical treatments, transportation systems, or software/digital platforms. The fund's portfolio, comprising approximately 50 holdings, features significant allocations to sectors including information technology (around 33%), health care (around 30%), and communication services (around 16%), with top holdings such as NVIDIA Corp., Netflix Inc., Alphabet Inc. Class C, Insmed Inc., and iRhythm Technologies Inc.; it maintains a net expense ratio of 0.50% and is sub-advised by Newton Investment Management North America, LLC, a BNY Mellon affiliate, leveraging its multi-dimensional research platform of fundamental, quantitative, and specialized teams. Launched on May 16, 2023, and listed on Nasdaq, BKIV operates primarily in the U.S. developed market equity space within the mid-cap growth category, targeting investors seeking exposure to sustainable growth prospects from cutting-edge innovation; it is managed by BNY Mellon ETF Investment Adviser, LLC, with John Porter as portfolio manager since inception. In a significant recent development, the fund is scheduled to liquidate on or about September 19, 2025, with trading ceasing after September 12, 2025, marking a major operational change amid BNY Mellon's broader ETF strategy shifts, including announced reorganizations of certain mutual funds into ETFs; no notable acquisitions, partnerships, funding rounds, or new product launches specific to BKIV have been reported in the last 1-2 years. The fund, part of BNY Mellon ETF Trust, maintains total net assets of approximately $17 million, with shares traded like stocks during market hours for liquidity.